Try a new search

Format these results:

Searched for:



Total Results:


A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet [Case Report]

Dorcely, Brenda; Nitis, Juliana; Schwartzbard, Arthur; Newman, Jonathan; Goldberg, Ira; Sum, Melissa
INTRODUCTION/BACKGROUND:Sodium-glucose cotransporter-2 [SGLT2] inhibitors reduce cardiovascular events and mortality in patients with diabetes, particularly patients with established cardiovascular disease. Euglycemic diabetic ketoacidosis [euDKA], a complication of SGLT2 therapy, can be exacerbated by a low carbohydrate diet. CASE REPORT/METHODS:A 61-year-old man with a history of type 2 diabetes, taking a SGLT2 inhibitor empagliflozin 10 mg orally daily, presented to the emergency room with a 2-day history of nausea and chest pain. A week prior to presentation, he had started a ketogenic diet. He was initially admitted with a diagnosis of acute coronary syndrome. On initial assessment in the emergency room, his cardiac enzymes were normal and there were no ischemic changes in his ECG. As there was concern for unstable angina, he underwent cardiac catheterization, which showed a known total occlusion with collaterals and arteries with non-obstructive disease without evidence of acute plaque rupture. His baseline laboratory assessments revealed an elevated anion gap of 17, increased urinary and plasma ketones, and metabolic acidosis. His plasma glucose level was 84 mg/dL. The diagnosis of euDKA was made, and treatment with intravenous fluids and insulin was initiated. His chest pain and nausea subsequently resolved. CONCLUSION/CONCLUSIONS:We present a case of euDKA triggered by a ketogenic diet while on SGLT2 inhibitor therapy presenting as chest pain. The recognition of euDKA is important in the context of increased SGLT2 use for management of cardiovascular risk for patients with diabetes.
PMID: 32178617
ISSN: 1875-6417
CID: 4353492

Functional Magnetic Resonance Imaging in Primary Hyperparathyroidism

Gazes, Yunglin; Liu, Minghao; Sum, Melissa; Cong, Elaine; Kuo, Jennifer; Lee, James A; Silverberg, Shonni; Stern, Yaakov; Walker, Marcella
OBJECTIVE:The neurophysiological mechanisms underlying cognitive dysfunction in primary hyperparathyroidism (PHPT) and brain regions affected are not clear. We assessed neural activation during cognitive testing (matrix reasoning, paired associates, and logical memory) using functional magnetic resonance imaging (fMRI) in 23 patients with PHPT and 23 healthy controls. A subset with PHPT was re-assessed 6 months post- parathyroidectomy (PTX). DESIGN/METHODS:This is an observational study comparing neural activation by fMRI in patients with PHPT to normative controls. Postmenopausal women were studied at a tertiary referral center. RESULTS:There were no between-group differences in cognitive task performance. Patients with PHPT had lower neural activation versus controls (max Z = 4.02, all p<0.01) during matrix reasoning in brain regions involved in executive function [left frontal lobe (k=57) and right medial frontal gyrus (k=72)] and motor function [right precentral gyrus (k=51)]. During paired associates (verbal memory), those with PHPT had greater activation in the right inferior parietal lobule (language/mathematical operations; k=65, p<0.01). Greater activation in this region bilaterally correlated with higher PTH (k=96, p<0.01). Post-PTX, activation decreased during matrix reasoning, but in different regions than those affected pre-PTX. CONCLUSIONS:PHPT is associated with differences in task-related neural activation patterns, but no difference in cognitive performance. While this may indicate compensation to maintain the same cognitive function, there was no clear improvement in neural activation after PTX. Larger, longitudinal studies that include PHPT patients followed without surgery are needed to determine if PTX could prevent worsening of altered neural activation patterns in PHPT.
PMID: 32348956
ISSN: 1479-683x
CID: 4436942

ATRAID regulates the action of nitrogen-containing bisphosphonates on bone

Surface, Lauren E; Burrow, Damon T; Li, Jinmei; Park, Jiwoong; Kumar, Sandeep; Lyu, Cheng; Song, Niki; Yu, Zhou; Rajagopal, Abbhirami; Bae, Yangjin; Lee, Brendan H; Mumm, Steven; Gu, Charles C; Baker, Jonathan C; Mohseni, Mahshid; Sum, Melissa; Huskey, Margaret; Duan, Shenghui; Bijanki, Vinieth N; Civitelli, Roberto; Gardner, Michael J; McAndrew, Chris M; Ricci, William M; Gurnett, Christina A; Diemer, Kathryn; Wan, Fei; Costantino, Christina L; Shannon, Kristen M; Raje, Noopur; Dodson, Thomas B; Haber, Daniel A; Carette, Jan E; Varadarajan, Malini; Brummelkamp, Thijn R; Birsoy, Kivanc; Sabatini, David M; Haller, Gabe; Peterson, Timothy R
Nitrogen-containing bisphosphonates (N-BPs), such as alendronate, are the most widely prescribed medications for diseases involving bone, with nearly 200 million prescriptions written annually. Recently, widespread use of N-BPs has been challenged due to the risk of rare but traumatic side effects such as atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ). N-BPs bind to and inhibit farnesyl diphosphate synthase, resulting in defects in protein prenylation. Yet, it remains poorly understood what other cellular factors might allow N-BPs to exert their pharmacological effects. Here, we performed genome-wide studies in cells and patients to identify the poorly characterized gene, ATRAID Loss of ATRAID function results in selective resistance to N-BP-mediated loss of cell viability and the prevention of alendronate-mediated inhibition of prenylation. ATRAID is required for alendronate inhibition of osteoclast function, and ATRAID-deficient mice have impaired therapeutic responses to alendronate in both postmenopausal and senile (old age) osteoporosis models. Last, we performed exome sequencing on patients taking N-BPs that suffered ONJ or an AFF. ATRAID is one of three genes that contain rare nonsynonymous coding variants in patients with ONJ or an AFF that is also differentially expressed in poor outcome groups of patients treated with N-BPs. We functionally validated this patient variation in ATRAID as conferring cellular hypersensitivity to N-BPs. Our work adds key insight into the mechanistic action of N-BPs and the processes that might underlie differential responsiveness to N-BPs in people.
PMID: 32434850
ISSN: 1946-6242
CID: 4446942

Cognition and cerebrovascular function in primary hyperparathyroidism before and after parathyroidectomy

Liu, M; Sum, M; Cong, E; Colon, I; Bucovsky, M; Williams, J; Kepley, A; Kuo, J; Lee, J A; Lazar, R M; Marshall, R; Silverberg, S; Walker, M D
PURPOSE/OBJECTIVE:There are cognitive changes in primary hyperparathyroidism (PHPT) that improve with parathyroidectomy, but the mechanism of cognitive dysfunction has not been delineated. We assessed if cerebrovascular function is impaired in PHPT, improves post-parathyroidectomy and is associated with PTH level and cognitive dysfunction. METHODS:This is an observational study of 43 patients with mild hypercalcemic or normocalcemic PHPT or goiter. At baseline, cerebrovascular function (dynamic cerebral autoregulation and vasomotor reactivity) by transcranial Doppler and neuropsychological function were compared between all three groups. A subset underwent parathyroidectomy or thyroidectomy, and was compared 6 months post-operatively. RESULTS:Mean cerebrovascular and neuropsychological function was normal and no worse in PHPT compared to controls preoperatively. Higher PTH was associated with worse intracerebral autoregulation (r = - 0.43, p = 0.02) and worse cognitive performance on some tests. Post-parathyroidectomy, mood improved significantly, but changes did not differ compared to those having thyroidectomy (p = 0.84). There was no consistent improvement in cognition or change in vascular function in either surgical group. CONCLUSIONS:Although higher PTH was associated with worse intracerebral autoregulation, cerebrovascular function, cognition and mood were normal in mild PHPT. PTX did not improve vascular or cognitive function. The observed improvement in mood cannot be clearly attributed to PTX. Notwithstanding the small sample size, the results do not support changing current criteria for parathyroidectomy to include cognitive complaints. However, the associations between PTH, cognition and cerebral autoregulation merit future studies in those with more severe hyperparathyroidism.
PMID: 31621051
ISSN: 1720-8386
CID: 4140572

Acute hypocalcemia from proton pump inhibitor use

Chapter by: Vallejo, Franco; Sum, Melissa
in: Hypoparathyroidism: A Clinical Casebook by
[S.l.] : Springer International Publishing, 2019
pp. 9-15
ISBN: 9783030294328
CID: 4543732

Incidental thyroid carcinoma in graves'disease-should we be concerned? [Meeting Abstract]

Ho, E; Cheng, Y; Liu, C; Sum, M; Ogilvie, J; Givi, B; Patel, K
The incidence of thyroid cancer in Graves'Disease (GD) patients is estimated to be low. However, it is unclear what impact the recent rise in the incidence of thyroid cancers has had in this population. Furthermore, it is not clear if these cancers behave more aggressively than cancers in the general population. We investigated the incidence of malignancy and its features in a contemporary cohort of GD patients treated by surgery. All patients who underwent thyroidectomy for GD in our center were reviewed from 2013-2018. Demographics, clinicopathologic features, rate of incidental cancer and outcomes were reviewed. We identified 130 patients with GD who underwent thyroidectomy. Median age was 40.5 (16-80). Majority were female (112, 86%). All but five (4%) were radioactive iodine naive. Thirtyfour (26%) were found to harbor malignancy. While the majority (18, 53%) were papillary microcarcinoma; 12 (34%) had multifocal disease; 10 (29%) had tall cell features, 3 (9%) had positive lymph nodes, and 2 (6%) had extrathyroidal extension. One patient (3%) was diagnosed with follicular carcinoma. No permanent hyperparathyroidism or recurrent laryngeal nerve injury was encountered. With a median follow up of 23 months no recurrences were identified. The risk of incidental malignancy in GD patients was high in our cohort. While the majority were low risk microcarcinomas, a number of patients harbored higher risk tall cell features. Our data suggest that for GD patients who are medically managed, careful surveillance and biopsy of suspicious nodules might be warranted. The outcome of surgical treatment was excellent for controlling both hyperthyroidism and cancer
ISSN: 1557-9077
CID: 4187912

Clinical and Diffusion Tensor MRI Findings in Congenital Homonymous Hemianopia

Rispoli, Joanne; Seay, Meagan; Sum, Melissa; Rucker, Janet C; Shepherd, Timothy M
PMID: 30865055
ISSN: 1536-5166
CID: 3733222

Chinese Women in Both the United States and Hong Kong Have Cortical Microstructural Advantages and More Trabecular Plates Compared With White Women

Sum, Melissa; Zhu, Tracy Y; Zhou, Bin; Zhang, Zhendong; Bilezikian, John P; Guo, X Edward; Qin, Ling; Walker, Marcella
We cross-sectionally compared racial differences in bone quality between Chinese women in the United States (US) and Hong Kong (HK) with white women. A total of 514 women were included. We measured bone geometry, mass, microstructure, and stiffness by high-resolution peripheral quantitative computed tomography (HR-pQCT), individual trabecula segmentation (ITS), and microfinite element analysis (μFEA). After adjustment for age and body mass index (BMI), premenopausal Chinese women in the US and HK had smaller bone area but greater radial cortical (Ct.) thickness and Ct. and trabecular (Tb.) volumetric bone mineral density (vBMD) versus white women but did not differ from each other. At the radius, Tb. number was lower and spacing greater in Chinese women from HK and the US versus white women, whereas Chinese women did not differ from each other. Tb. thickness was highest in Chinese women from HK, intermediate in Chinese-Americans, and lowest in white women. Chinese women had more trabecular plates versus white women, leading to greater age- and BMI-adjusted stiffness for premenopausal Chinese women in HK and the US (both p < 0.05) versus white women. Tibial differences were similar in premenopausal women; analogous trends in microstructure were present in postmenopausal women at the tibia, although stiffness did not differ. In contrast, at the radius, cortical, plate-to-rod ratio, and stiffness were similar between postmenopausal HK and white women. Adjusting for age, weight, and height rather than age and BMI tended to reduce differences in bone size and Tb. parameters but accentuate cortical differences such that Chinese premenopausal women in both locations and postmenopausal women from HK had higher stiffness at both skeletal sites compared with white women. Compared with white women, Chinese women in the US and HK have vBMD and microstructural advantages leading to higher or similar mechanical competence in pre- and postmenopausal women, respectively, despite smaller bone size.
PMID: 31044182
ISSN: 2473-4039
CID: 3834682

Immunotherapy-induced autoimmune diabetes and concomitant hypophysitis [Letter]

Sum, Melissa; Garcia, Franco Vallejo
PMID: 29476305
ISSN: 1573-7403
CID: 3150372

Brown tumors of primary hyperparathyroidism may be a source of extrarenal 1,25-dihydroxyvitamin D production [Letter]

Sum, Melissa; Larner, Dean; Hewison, Martin; Bilezikian, John P
PMID: 29556950
ISSN: 1559-0100
CID: 2996352